IPP Bureau

Aurobindo Pharma receives 10 observations for Unit IX
Aurobindo Pharma receives 10 observations for Unit IX

By IPP Bureau - November 21, 2022

The company had responded to the agency and carried out the required corrective actions.

Eugia Pharma receives USFDA approval for Amphotericin B Liposome for Injection
Eugia Pharma receives USFDA approval for Amphotericin B Liposome for Injection

By IPP Bureau - November 19, 2022

The product is expected to be launched by Q4 FY23.

Strides receives USFDA approval for Potassium Chloride Oral Solution
Strides receives USFDA approval for Potassium Chloride Oral Solution

By IPP Bureau - November 19, 2022

The approval further strengthens the Potassium Chloride franchise for the company.

Vivimed Labs Q2 FY2023 consolidated loss at Rs. 22.03 Cr
Vivimed Labs Q2 FY2023 consolidated loss at Rs. 22.03 Cr

By IPP Bureau - November 19, 2022

The company has reported total income of Rs. 44.37 crores during the period ended September 30, 2022

Strand Life Sciences launches ‘Strand Genomic Wellness’
Strand Life Sciences launches ‘Strand Genomic Wellness’

By IPP Bureau - November 18, 2022

Strand’s new offering will help people better understand and manage diseases through genomic sequencing

Apollo launches national program to promote rational use of antibiotics
Apollo launches national program to promote rational use of antibiotics

By IPP Bureau - November 18, 2022

Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes

Zydus Lifesciences gets exclusive marketing rights for CanAssist Breast
Zydus Lifesciences gets exclusive marketing rights for CanAssist Breast

By IPP Bureau - November 18, 2022

Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning

CPhI & P-MEC India expo to encourage cost-effective solutions in India’s march towards a Rs 10.5 lakh crore pharma market by 2030
CPhI & P-MEC India expo to encourage cost-effective solutions in India’s march towards a Rs 10.5 lakh crore pharma market by 2030

By IPP Bureau - November 17, 2022

The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees

Experts highlight the rising cases of diabetes in youngsters
Experts highlight the rising cases of diabetes in youngsters

By IPP Bureau - November 16, 2022

India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.

Cadila recognized for its contribution to leprosy treatment
Cadila recognized for its contribution to leprosy treatment

By IPP Bureau - November 16, 2022

Cadila Pharmaceuticals was felicitated during the plenary session of the 21st International Leprosy Congress

Intuitive  installs 100 robotic-assisted surgical system
Intuitive installs 100 robotic-assisted surgical system

By IPP Bureau - November 16, 2022

Prime Minister Narendra Modi attended an event marking the 100th robotic-assisted surgical system installation at U. N. Mehta Institute of Cardiology, Ahmedabad.

SMS Pharma revenue down 9%
SMS Pharma revenue down 9%

By IPP Bureau - November 15, 2022

Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market

Voltas forays into the bio medical refrigeration and cold chain
Voltas forays into the bio medical refrigeration and cold chain

By IPP Bureau - November 15, 2022

Ties up with Denmark’s Vestfrost Solutions, to cater to the unique needs of the Indian market

Biocon Q2FY23 net profit slips 10% to Rs 168 Cr; Revenue up 26%
Biocon Q2FY23 net profit slips 10% to Rs 168 Cr; Revenue up 26%

By IPP Bureau - November 15, 2022

IOL Chemicals and Pharmaceuticals Q2FY23 net profit drops to Rs 15.6 Cr
IOL Chemicals and Pharmaceuticals Q2FY23 net profit drops to Rs 15.6 Cr

By IPP Bureau - November 15, 2022

The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA

Latest Stories

Interviews

Packaging